Home/ Stocks/ SHPH

Shuttle Pharmaceuticals Holdings, Inc. Common Stock

SHPH XNAS

$3.54 -0.27 (-6.96%) ▼ 15-min delayed

Open

$3.69

High

$3.74

Low

$3.50

Volume

55.3K

Market Cap

$2.27M

About Shuttle Pharmaceuticals Holdings, Inc. Common Stock

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-2,152,471	$-0.43
FY 2025	$-9,516,824	$-11,721,669	$-7.16
Q3 2025	$0	$-2,347,302	$-1.05
Q1 2025	$0	$-3,000,000	$-0.30

TickerDaily Coverage

Why Is Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Stock Up 66.9% Today?

Penny Stocks Marcus Rivera · Jul 14, 2026

Shuttle Pharmaceuticals Holdings (SHPH) stock ripped 66.9% higher Tuesday, closing at $4.85 on...

View All Coverage →

Get SHPH Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Shuttle Pharmaceuticals Holdings, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.